Athenahealth, Inc.
ATHN
ATHN was delisted on the 11th of February, 2019.
0 hedge funds and large institutions have $0 invested in Athenahealth, Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 261 closing their positions.
100% less funds holding
Funds holding: 263 → 0 (-263)
100% less funds holding in top 10
Funds holding in top 10: 19 → 0 (-19)
100% less capital invested
Capital invested by funds: $5.08B → $0 (-$5.08B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 261
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$593M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$474M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$323M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$248M |
| 5 |
BlackRock
New York
|
-$237M |
ATHN Hedge Fund Activity: Q1 2019 in Review
0 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Athenahealth, Inc. (ATHN) for Q1 2019, worth a combined $0 — down 100% from $5.08B a quarter earlier.
Sellers outnumbered buyers: 261 funds closed out of ATHN and 0 opened new positions — a net loss of 261 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Morgan Stanley, exiting entirely with an estimated $593M sold.
- 0 institutional investors held Athenahealth, Inc. (ATHN) as of Q1 2019, down from 263 in Q4 2018.
- Funds reported $0 of Athenahealth, Inc. stock for Q1 2019, down 100% quarter-over-quarter.
- 0 funds opened new Athenahealth, Inc. positions in Q1 2019 and 261 closed out, a net change of -261 holders.
- The largest Athenahealth, Inc. seller in Q1 2019 was Morgan Stanley, an estimated $593M sold.
Based on aggregated 13F filings for Q1 2019.